Form POS AM Esperion Therapeutics, Jul 13, 2026 12:05PM

 

As filed with the Securities and Exchange Commission on July 13, 2026

 

Registration No. 333-286631

Registration No. 333-264303

Registration No. 333-258396

Registration No. 333-208701

Registration No. 333-202859

Registration No. 333-201198

Registration No. 333-197125

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

POST-EFFECTIVE AMENDMENT NO. 1 TO:

 

FORM S-3 REGISTRATION STATEMENT NO. 333-286631

FORM S-3... (continue reading...)


Form 424B2 ROYAL BANK OF CANADA Jul 13, 2026 12:05PM

The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

Registration Statement No. 333-275898

Filed Pursuant to Rule 424(b)(2)

Subject to Completion. Dated July 13, 2026.

Pricing Supplement to the Prospectus dated December 20, 2023, the Series J Prospectus... (continue reading...)


Form 424B2 MORGAN STANLEY Jul 13, 2026 12:04PM

Preliminary Pricing Supplement No. 17,327

Registration Statement Nos. 333-293641; 333-293641-01

Dated July 13, 2026

Filed pursuant to Rule 424(b)(2)

Morgan Stanley Finance LLC

Structured Investments

Dual Directional Buffered Participation Securities with Downside Factor due July 28, 2027

Based... (continue reading...)


Form POS AM Esperion Therapeutics, Jul 13, 2026 12:04PM

 

As filed with the Securities and Exchange Commission on July 13, 2026

 

Registration No. 333-286631

Registration No. 333-264303

Registration No. 333-258396

Registration No. 333-208701

Registration No. 333-202859

Registration No. 333-201198

Registration No. 333-197125

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

POST-EFFECTIVE AMENDMENT NO. 1 TO:

 

FORM S-3 REGISTRATION STATEMENT NO. 333-286631

FORM S-3... (continue reading...)


Form POS462B Esperion Therapeutics, Jul 13, 2026 12:03PM

 

As filed with the Securities and Exchange Commission on July 13, 2026

 

Registration No. 333-286631

Registration No. 333-264303

Registration No. 333-258396

Registration No. 333-208701

Registration No. 333-202859

Registration No. 333-201198

Registration No. 333-197125

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

POST-EFFECTIVE AMENDMENT NO. 1 TO:

 

FORM S-3 REGISTRATION STATEMENT NO. 333-286631

FORM S-3... (continue reading...)


More SEC Filings

View Older Stories

Jul 13, 2026 12:03PM Form 4 Fundrise Income Real For: Jul 10 Filed by: Starr Gayle P
Jul 13, 2026 12:03PM Form 4/A H2O AMERICA For: Jul 07 Filed by: ATLAS Infrastructure Partners (UK) Ltd.
Jul 13, 2026 12:03PM Form 424B2 UBS AG
Jul 13, 2026 12:03PM Form D FCP Venture X QP LLC,
Jul 13, 2026 12:02PM Form 497 Tidal Trust III
Jul 13, 2026 12:02PM Form D Series 18-4, a series
Jul 13, 2026 12:02PM Form 497K EA Series Trust
Jul 13, 2026 12:01PM Form POS AM Esperion Therapeutics,
Jul 13, 2026 12:01PM Form F-6EF Amundi S.A./ADR Filed by: BANK OF NEW YORK / ADR DIVISION
Jul 13, 2026 12:01PM Form 4 Texas Pacific Land Corp For: Jul 10 Filed by: HORIZON KINETICS ASSET MANAGEMENT LLC
Jul 13, 2026 12:00PM Form POS AM Esperion Therapeutics,
Jul 13, 2026 12:00PM Form 13F-HR DAVENPORT & Co LLC For: Jun 30
Jul 13, 2026 12:00PM Form 6-K Mint Inc Ltd For: Jul 13
Jul 13, 2026 11:59AM Form 424B2 UBS AG
Jul 13, 2026 11:58AM Form 424B2 MORGAN STANLEY
Jul 13, 2026 11:58AM Form D/A Institutional Drilling
Jul 13, 2026 11:58AM Form POS AM Esperion Therapeutics,
Jul 13, 2026 11:58AM Form N-PX Lindsell Train Ltd For: Jun 30
Jul 13, 2026 11:58AM Form 497 EA Series Trust
Jul 13, 2026 11:58AM Form CERT Shell Finance US Inc.
Jul 13, 2026 11:58AM Form 424B2 MORGAN STANLEY
Jul 13, 2026 11:57AM Form N-PX Intelligent Financial For: Jun 30
Jul 13, 2026 11:57AM Form POS AM Esperion Therapeutics,
Jul 13, 2026 11:56AM Form CERT Shell plc
Jul 13, 2026 11:56AM Form FWP GOLDMAN SACHS GROUP INC Filed by: GOLDMAN SACHS GROUP INC
Jul 13, 2026 11:56AM Form FWP GS Finance Corp. Filed by: GS Finance Corp.
Jul 13, 2026 11:55AM Form 424B2 UBS AG
Jul 13, 2026 11:55AM Form D MDHGEB5 LLC
Jul 13, 2026 11:55AM Form N-CEN Peachtree Alternative For: Apr 30
Jul 13, 2026 11:55AM Form S-8 POS Esperion Therapeutics,
Jul 13, 2026 11:54AM Form 424B2 CITIGROUP INC
Jul 13, 2026 11:54AM Form S-8 POS Esperion Therapeutics,
Jul 13, 2026 11:54AM Form 4/A NorthWestern Energy Grou For: Jul 09 Filed by: YAZDI MAHVASH
Jul 13, 2026 11:54AM Form 424B2 UBS AG
Jul 13, 2026 11:53AM Form D/A Hudson Bay Cap Structure
Jul 13, 2026 11:53AM Form S-8 POS Esperion Therapeutics,
Jul 13, 2026 11:52AM Form S-8 POS Esperion Therapeutics,
Jul 13, 2026 11:52AM Form 13F-HR Avondale Wealth Manageme For: Jun 30
Jul 13, 2026 11:51AM Form 424B2 GOLDMAN SACHS GROUP INC
Jul 13, 2026 11:51AM Form 424B2 MORGAN STANLEY
Jul 13, 2026 11:51AM Form S-8 POS Esperion Therapeutics,
Jul 13, 2026 11:50AM Form 4 RENN Fund, Inc. For: Jul 10 Filed by: HORIZON KINETICS ASSET MANAGEMENT LLC
Jul 13, 2026 11:50AM Form N-PX Hyperion Asset Managemen For: Jun 30
Jul 13, 2026 11:50AM Form 424B2 UBS AG
Jul 13, 2026 11:50AM Form 4 COMMERCIAL METALS Co For: Jul 10 Filed by: MATT PETER R
Jul 13, 2026 11:50AM Form 15-12G Stellar Bancorp, Inc.
Jul 13, 2026 11:50AM Form 424B2 GOLDMAN SACHS GROUP INC
Jul 13, 2026 11:50AM Form S-8 POS Esperion Therapeutics,
Jul 13, 2026 11:49AM Form 424B2 MORGAN STANLEY
Jul 13, 2026 11:49AM Form 424B2 UBS AG
View Older Stories